Novel compounds.

Abstract

"The present invention relates to a compound of the formula (I): Wherein R1 is selected from the group consisting of (1), (2), (3) (4) and (5) as defined in Wie specification, Ra, Rb and Rc are independently hydrdgen or C^alkyl; R2 is halogen, C^alkyl, CF3, hydroxy or Cv 6alkoxy; R3 is halogen, CF3, hydroxy, C^alkoxy, CRdReOH or CHF2; in which Rd and Re are independently hydrogen or methyl; R4 is hydrogen, halogen, ChalkyI or CF3; R5 and R6 are independently hydrogen, halogen or C^alkyl; and n is 0 or 1. process for preparation of compound of formula (I) and pharmaceutical' composition comprising thereof, for use in the therapy, in particular in the treatment of a disease or condition for which a CCR4 receptor antagonist is indicated.